Clearbridge Investments LLC trimmed its holdings in Haleon plc (NYSE:HLN - Free Report) by 12.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 32,803,243 shares of the company's stock after selling 4,567,165 shares during the quarter. Clearbridge Investments LLC owned about 0.72% of Haleon worth $312,943,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in HLN. Addison Advisors LLC boosted its holdings in Haleon by 28.7% in the fourth quarter. Addison Advisors LLC now owns 4,954 shares of the company's stock valued at $47,000 after acquiring an additional 1,106 shares during the last quarter. Synovus Financial Corp lifted its position in Haleon by 0.8% during the 3rd quarter. Synovus Financial Corp now owns 148,834 shares of the company's stock valued at $1,575,000 after purchasing an additional 1,216 shares during the period. Haverford Trust Co boosted its stake in shares of Haleon by 5.0% in the 4th quarter. Haverford Trust Co now owns 25,842 shares of the company's stock valued at $247,000 after purchasing an additional 1,233 shares during the last quarter. Greenleaf Trust grew its position in shares of Haleon by 8.4% during the 4th quarter. Greenleaf Trust now owns 17,225 shares of the company's stock worth $164,000 after buying an additional 1,333 shares during the period. Finally, Baron Wealth Management LLC lifted its holdings in Haleon by 4.3% in the fourth quarter. Baron Wealth Management LLC now owns 33,632 shares of the company's stock valued at $321,000 after buying an additional 1,381 shares during the period. Institutional investors and hedge funds own 6.67% of the company's stock.
Wall Street Analyst Weigh In
HLN has been the subject of several recent research reports. Hsbc Global Res cut shares of Haleon from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, March 5th. Sanford C. Bernstein lowered Haleon from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 8th. Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Haleon in a report on Monday, March 3rd. Morgan Stanley cut Haleon from an "overweight" rating to an "equal weight" rating in a research note on Friday, January 10th. Finally, HSBC reissued a "hold" rating on shares of Haleon in a research note on Wednesday, March 5th. Six research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus target price of $10.95.
View Our Latest Analysis on HLN
Haleon Trading Up 3.0 %
Shares of Haleon stock traded up $0.30 during trading hours on Thursday, hitting $10.46. The company's stock had a trading volume of 9,174,658 shares, compared to its average volume of 6,604,315. Haleon plc has a 12 month low of $7.99 and a 12 month high of $10.80. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The company has a market capitalization of $47.35 billion, a PE ratio of 30.76, a price-to-earnings-growth ratio of 2.82 and a beta of 0.25. The stock has a 50 day moving average of $10.00 and a 200 day moving average of $9.87.
Haleon (NYSE:HLN - Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported $0.05 EPS for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The firm had revenue of $3.54 billion for the quarter, compared to the consensus estimate of $3.38 billion. Analysts predict that Haleon plc will post 0.43 earnings per share for the current year.
Haleon Increases Dividend
The business also recently announced a -- dividend, which will be paid on Thursday, June 5th. Investors of record on Friday, April 25th will be paid a $0.1166 dividend. The ex-dividend date is Friday, April 25th. This is a positive change from Haleon's previous -- dividend of $0.05. This represents a yield of 1.6%. Haleon's dividend payout ratio is presently 58.97%.
Haleon Profile
(
Free Report)
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
Featured Stories

Before you consider Haleon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Haleon wasn't on the list.
While Haleon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market volatility creates opportunity. Our analysts have pinpointed 10 stocks perfectly positioned for exceptional growth this spring, even amid economic uncertainty. Don't miss your chance to access this timely research and invest with confidence.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.